Cytarabine (Cytosine arabinoside)
Therapeutic agent (verify pharmacological class)
What it is used for
Acute myeloid leukemia (AML) which include - acute promyelocytic, monocytic, myelomonocytic, megakaryoblastic, and erythroid leukemias; acute lymphocytic leukemia (ALL); meningeal leukemia and other meningeal neoplasms; chronic myelogenous leukemia (CML); non-Hodgkin's lymphomas in children; myelodysplastic syndrome. It is used principally as a component of various chemotherapeutic regimens.
Warnings
Only physicians experienced in cancer chemotherapy should use it; increased incidence of infections; increased incidence of hemorrhagic complications; blood counts should be performed at least once a week.
Possible side effects
Bone marrow suppression [main adverse reaction] with leukopenia, thrombocytopenia and anemia; nausea; vomiting; diarrhea and abdominal pain; oral ulceration; hepatic dysfunction
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.